Status:
UNKNOWN
Randomized Placebo Controlled Trial With Etoricoxib That is Taken to Prevent the Yom Kippur Headache
Lead Sponsor:
Shaare Zedek Medical Center
Conditions:
Headache
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Headache during fasting is a known entity in the scientific literature. The prevalence of such a headache is high and in a study conducted in Israel was found in 60% of people with a previous predilec...
Detailed Description
Fasting is a known trigger for headache. More specifically, headache associated with ritual fasting in compliance with religious edict has been documented and described in the literature. These have b...
Eligibility Criteria
Inclusion
- Age 18 -65.
- Patients will be enrolled if they declared that they intended to complete the 25 hour YK fast, and had demonstrated their commitment by doing so for the previous three years (unless medically prevented.)
- We will only enroll patients who stated that they typically suffered from headache during the fast.
Exclusion
- Patients with chronic medical problems including:
- Heart disease,
- Kidney disease,
- Liver disease,
- Peptic ulcer disease,
- Hypertension,
- Diabetes,
- Lung disease including asthma,
- History of gastrointestinal bleeding,
- Patients with allergies or intolerance in the past to NSAIDs,
- Pregnancy or lactation.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2008
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00752921
Start Date
September 1 2008
End Date
October 1 2008
Last Update
September 16 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaare Zedek Medical Center
Jerusalem, Israel, 91031